Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2000
09/21/2000WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055314A2 Inhibitors of endothelin-1 synthesis
09/21/2000WO2000055191A2 Recombinant haemophilus influenzae adhesin proteins
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054798A1 Antiviral agent in the form of nose drops
09/21/2000WO2000054780A2 Corticosteroid formulation
09/21/2000WO2000054770A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000WO2000054758A2 Method for delivering benzidine prostaglandins by inhalation
09/21/2000WO2000054748A1 Metered dose inhalers with isobutane as propellant
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000025766A3 Use of nk antagonist for treating gastric asthma
09/21/2000WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity
09/21/2000DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2367611A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364667A1 Recombinant haemophilus influenzae adhesin proteins
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361819A1 Amide derivatives
09/21/2000CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000CA2361503A1 Corticosteroid formulation
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036076A1 Novel compounds
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1035857A1 Oral antioxidant preparation comprising selenium and reduced glutathione
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP1035846A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1267221A Method of enhancing bioavailability of fexofenadine and its derivs.
09/20/2000CN1267215A Pharmacetical compositions contg. effervescent acid-base couple
09/20/2000CN1266693A Chinese medicinal composition for treating asthma and preparing process thereof
09/20/2000CN1056605C Compounds as selective human NK 3-receptor antagonists and their use
09/20/2000CN1056533C 'Baizhong' plaster for children
09/20/2000CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics
09/19/2000US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/19/2000US6121290 Use of GABA uptake inhibitors as anti-tussive agents
09/19/2000US6121286 Antileukotriene activity and antihistaminic activity, for treating asthma; compounds such as 6-methoxy-3-(2-(3-(2-quinolylmethoxy)benzyl)tetrazolyl)quinolin-2-one
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121262 Neurokin (tachykinin) antagonists
09/19/2000US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
09/19/2000US6120795 Encapsulation
09/19/2000US6120752 Vial equipped with dispensing valve
09/19/2000US6119687 Partial liquid breathing of fluorocarbons
09/19/2000CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors
09/19/2000CA2053242C Protease inhibitor
09/14/2000WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053600A1 Novel piperidine derivatives
09/14/2000WO2000053596A2 Imidazole compounds as histamine h3 ligands
09/14/2000WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053221A1 Intranasal delivery of pneumococcal polysaccharide vaccines
09/14/2000WO2000053198A1 Inhibitor of lipoxygenase pathways
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000038737A3 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
09/14/2000WO2000037422A3 Ion channel modulating agents
09/14/2000WO2000037068B1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000023599A3 Human proteins involved in endoplasmic reticulum protein degradation
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000DE19911064A1 Dosieraerosole mit Isobutan als Treibmittel MDIs containing isobutane as a propellant
09/14/2000DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000CA2364442A1 Intranasal delivery of pneumococcal polysaccharide vaccines
09/14/2000CA2363593A1 Nucleic acid respiratory syncytial virus vaccines
09/14/2000CA2362319A1 Imidazole compounds as histamine h3 ligands
09/13/2000EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
09/13/2000EP1034792A1 Intranasal delivery of pneumococcal polysaccharide vaccines
09/13/2000EP1034171A1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl1]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
09/13/2000EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
1 ... 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 ... 878